Evidence map›Paper›PMID 28486019›Full record

ArticleTissue engineering. Part A2018

Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.

Takuma Fukunishi, Cameron A Best, Chin Siang Ong, Tyler Groehl, James Reinhardt, Tai Yi, Hideki Miyachi, Huaitao Zhang, Toshiharu Shinoka, Christopher K Breuer and 2 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04325789 (A Prospective Randomized Multicenter Evaluation of Rotator Cuff Healing Using a Nanofiber Scaffold in Patients Greater Than 55 Years), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04325789 nacompletednot on this mapstarted 2020, after this paper: background citation

A Prospective Randomized Multicenter Evaluation of Rotator Cuff Healing Using a Nanofiber Scaffold in Patients Greater Than 55 Years

TypeinterventionalSponsorAtreon OrthopedicsRan2020 to 2025Enrolled91ConditionsRotator Cuff Tears, Full-thickness Rotator Cuff TearsArmsnanofiber scaffold
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Hemodynamics and Wall Mechanics of Vascular Graft Failure.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Bone Tissue Engineering in the Treatment of Bone Defects.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Factors Influencing Poor Outcomes in Synthetic Tissue-Engineered Tracheal Replacement.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Takuma Fukunishi1 Department of Cardiac Surgery, Johns Hopkins University , Baltimore, Maryland.
Cameron A Best2 Tissue Engineering and Surgical Research, Nationwide Children's Hospital , Columbus, Ohio.
Chin Siang Ong1 Department of Cardiac Surgery, Johns Hopkins University , Baltimore, Maryland.
Tyler Groehl3 Nanofiber Solutions, Inc. , Columbus, Ohio.
James Reinhardt2 Tissue Engineering and Surgical Research, Nationwide Children's Hospital , Columbus, Ohio.
Tai Yi2 Tissue Engineering and Surgical Research, Nationwide Children's Hospital , Columbus, Ohio.
Hideki Miyachi2 Tissue Engineering and Surgical Research, Nationwide Children's Hospital , Columbus, Ohio.
Huaitao Zhang1 Department of Cardiac Surgery, Johns Hopkins University , Baltimore, Maryland.
Toshiharu Shinoka2 Tissue Engineering and Surgical Research, Nationwide Children's Hospital , Columbus, Ohio.
Christopher K Breuer2 Tissue Engineering and Surgical Research, Nationwide Children's Hospital , Columbus, Ohio.
Jed Johnson3 Nanofiber Solutions, Inc. , Columbus, Ohio.
Narutoshi Hibino1 Department of Cardiac Surgery, Johns Hopkins University , Baltimore, Maryland.
Nationwide Children's Hospital · USJohns Hopkins University · US

Funding

Training Program in Cellular and Molecular MedicineT32GM008752 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI RAO, RAJINI · 2000 to 2019
$11.7M
Improving Tissue Engineered Vascular Graft Performance via Computational ModelingR01HL139796 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BREUER, CHRISTOPHER KANE, HUMPHREY, JAY D. · 2018 to 2025
$6.4M
Mechanisms of Vascular Neotissue Formation In Tissue Engineered Vascular GraftsR01HL098228 · NHLBI · YALE UNIVERSITY · PI BREUER, CHRISTOPHER KANE · 2010 to 2018
$3.6M
Development of an Improved Vascular Graft for Use in Congenital Heart SurgeryR01HL128847 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BREUER, CHRISTOPHER KANE · 2016 to 2019
$2.8M
Computational Model Driven Design of Tissue Engineered Vascular GraftsR01HL128602 · NHLBI · YALE UNIVERSITY · PI BREUER, CHRISTOPHER KANE, HUMPHREY, JAY D. · 2015 to 2018
$2.2M
NHLBI NIH HHS R01 HL098228NHLBI NIH HHS R01 HL128847NHLBI NIH HHS R01 HL139796NIGMS NIH HHS T32 GM008752
6 · The paper itself

Abstract

objectiveElectrospinning is a promising technology that provides biodegradable nanofiber scaffolds for cardiovascular tissue engineering. However, success with these materials has been limited, and the optimal combination of scaffold parameters for a tissue-engineered vascular graft (TEVG) remains elusive. The purpose of the present study is to evaluate the effect of bone marrow mononuclear cell (BM-MNC) seeding in electrospun scaffolds to support the rational design of optimized TEVGs.

methodsNanofiber scaffolds were fabricated from co-electrospinning a solution of polyglycolic acid and a solution of poly(ι-lactide-co-ɛ-caprolactone) and characterized with scanning electron microscopy. Platelet activation and cell seeding efficiency were assessed by ATP secretion and DNA assays, respectively. Cell-free and BM-MNC seeded scaffolds were implanted in C57BL/6 mice (n = 15/group) as infrarenal inferior vena cava (IVC) interposition conduits. Animals were followed with serial ultrasonography for 6 months, after which grafts were harvested for evaluation of patency and neotissue formation by histology and immunohistochemistry (n = 10/group) and PCR (n = 5/group) analyses.

resultsBM-MNC seeding of electrospun scaffolds prevented stenosis compared with unseeded scaffolds (seeded: 9/10 patent vs. unseeded: 1/10 patent, p = 0.0003). Seeded vascular grafts demonstrated concentric laminated smooth muscle cells, a confluent endothelial monolayer, and a collagen-rich extracellular matrix. Platelet-derived ATP, a marker of platelet activation, was significantly reduced after incubating thrombin-activated platelets in the presence of seeded scaffolds compared with unseeded scaffolds (p < 0.0001). In addition, reduced macrophage infiltration and a higher M2 macrophage percentage were observed in seeded grafts.

conclusionsThe beneficial effects of BM-MNC seeding apply to electrospun TEVG scaffolds by attenuating stenosis through the regulation of platelet activation and inflammatory macrophage function, leading to well-organized neotissue formation. BM-MNC seeding is a valuable technique that can be used in the rational design of optimal TEVG scaffolds.

Indexed as

AnimalsBlood Vessel ProsthesisBone Marrow CellsCells, CulturedFemaleImmunohistochemistryMiceMice, Inbred C57BLTissue EngineeringTissue Scaffoldsbiodegradable scaffoldbone marrow mononuclear cell (BM-MNC) seedingelectrospinningnanofiberstenosistissue-engineered vascular graft (TEVG)

Identifiers

PMID28486019
PMCPMC5770093
OpenAlexW2625102433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.